These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11578562)

  • 21. Misperceptions about beta-blockers and diuretics: a national survey of primary care physicians.
    Ubel PA; Jepson C; Asch DA
    J Gen Intern Med; 2003 Dec; 18(12):977-83. PubMed ID: 14687255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-minimization analysis of initial antihypertensive therapy in patients with mild-to-moderate essential diastolic hypertension.
    Hilleman DE; Mohiuddin SM; Lucas BD; Stading JA; Stoysich AM; Ryschon K
    Clin Ther; 1994; 16(1):88-102; discussion 87. PubMed ID: 7911403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prescribing patterns and therapeutic implications for diabetic hypertension in Bahrain.
    Al Khaja KA; Sequeira RP; Mathur VS
    Ann Pharmacother; 2001 Nov; 35(11):1350-9. PubMed ID: 11724081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care.
    Mazzaglia G; Mantovani LG; Sturkenboom MC; Filippi A; Trifirò G; Cricelli C; Brignoli O; Caputi AP
    J Hypertens; 2005 Nov; 23(11):2093-100. PubMed ID: 16208153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic choice in the treatment of hypertension. Initial treatment of newly diagnosed hypertension and secular trends in the prescribing of antihypertensive medications for Medicaid patients.
    Ray WA; Schaffner W; Oates JA
    Am J Med; 1986 Dec; 81(6C):9-16. PubMed ID: 2879456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of severe arterial hypertension: cost of drug prescriptions in accordance with ANAES guidelines].
    Fender P; Guilhot J; Tilly B; Salanave B; Allemand H
    Therapie; 2001; 56(2):111-8. PubMed ID: 11471361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consumption and costs of antihypertensive drugs in Mexico: are diuretic agents a standing technological trajectory?
    Altagracia-Martínez M; Kravzov-Jinich J; Guadarrama-Atrizco MD; Rubio-Poo C; Wertheimer AI
    Res Social Adm Pharm; 2006 Mar; 2(1):22-37. PubMed ID: 17138499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The need for evidence in hypertension management: historical perspective.
    Moawad MA
    Ann Saudi Med; 2005; 25(5):367-74. PubMed ID: 16270757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic implications of evidence-based prescribing for hypertension: can better care cost less?
    Fischer MA; Avorn J
    JAMA; 2004 Apr; 291(15):1850-6. PubMed ID: 15100203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of antihypertensive therapy in Spain (1986-1994).
    Jabary NS; Herrero AM; Gonzalez JA
    Am J Hypertens; 2000 Jun; 13(6 Pt 1):607-10. PubMed ID: 10912742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Who is using antihypertensive drugs? A prescription analysis from Finland.
    Wallenius S; Peura S; Klaukka T; Enlund H
    Scand J Prim Health Care; 1996 Mar; 14(1):54-61. PubMed ID: 8725095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treating hypertension. Are the right drugs given to the right patients?
    Beaulieu MD; Dufresne L; LeBlanc D
    Can Fam Physician; 1998 Feb; 44():294-8, 301-2. PubMed ID: 9512833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypertension and common complications --analysis of the ambulatory treatment cost.
    Ivanova AD; Petrova GI
    Cent Eur J Public Health; 2009 Dec; 17(4):223-30. PubMed ID: 20377054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current prescription status of antihypertensive drugs with special reference to the use of diuretics in Japan.
    Ibaraki A; Goto W; Iura R; Tominaga M; Tsuchihashi T
    Hypertens Res; 2017 Feb; 40(2):203-206. PubMed ID: 27581534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Uncontrolled arterial hypertension: pharmaco-economic interest of hospital diagnostic work-up].
    Ragot S; Sosner P; Herpin D
    Arch Mal Coeur Vaiss; 2002; 95(7-8):733-7. PubMed ID: 12365089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temporal trends in antihypertensive drug prescriptions in Canada before and after introduction of the Canadian Hypertension Education Program.
    Campbell NR; McAlister FA; Brant R; Levine M; Drouin D; Feldman R; Herman R; Zarnke K;
    J Hypertens; 2003 Aug; 21(8):1591-7. PubMed ID: 12872055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Selection of pharmacologic treatment of arterial hypertension in primary care. Task force on Pharmacologic Approach of Hypertension in Primary Care (AFHAP)].
    Med Clin (Barc); 2000 Mar; 114(10):374-7. PubMed ID: 10786347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of hypertension at a health center. 1: The drugs prescribed for men are much more expensive than the ones prescribed for women].
    Johannesson M; Borgquist L; Elenstål A; Jönsson B; Tilling B
    Lakartidningen; 1991 Mar; 88(12):1096-8. PubMed ID: 2016944
    [No Abstract]   [Full Text] [Related]  

  • 40. Cost-effective therapy for hypertension.
    Barrie W
    West J Med; 1996 Apr; 164(4):303-9. PubMed ID: 8732729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.